hCAII-IN-8

• CAT Number: I042282
• CAS Number: 952306-80-8
• Molecular Formula: C15H16N2O5S
• Molecular Weight: 336.36
• Purity: ≥95%
• Synonyms: 3,4-dimethoxy-N-(3-sulfamoylphenyl)benzamide
• InChI: InChI=1S/C15H16N2O5S/c1-21-13-7-6-10(8-14(13)22-2)15(18)17-11-4-3-5-12(9-11)23(16,19)20/h3-9H,1-2H3,(H,17,18)(H2,16,19,20)
• InChIKey: NXXHQVMWOQRKGC-UHFFFAOYSA-N
• SMILES: COC1=C(C=C(C=C1)C(=O)NC2=CC(=CC=C2)S(=O)(=O)N)OC

hCAII-IN-8（Cat No.:I042282）is a small molecule inhibitor designed to target human carbonic anhydrase II (hCAII), an enzyme involved in regulating pH balance, fluid transport, and various physiological processes. Overexpression of hCAII has been implicated in certain diseases, including cancer, glaucoma, and osteoporosis. By inhibiting hCAII, hCAII-IN-8 aims to disrupt these processes, potentially offering therapeutic benefits in conditions where hCAII activity contributes to disease progression. Early studies suggest that hCAII-IN-8 could be effective in modulating the enzyme’s activity, providing a promising approach for treating conditions associated with abnormal hCAII expression.